GGrantIndex
← Search

GENOMICS SHARED RESOURCE

$251,169P30FY2009CANIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 39499645Paper 39392861Paper 39378878Paper 39332920Paper 39259591Paper 39207105Paper 39193906Paper 39127153Paper 39081315Paper 39028768Paper 39025270Paper 38902475Paper 38898085Paper 38896451Paper 38863869Paper 38778498Paper 38753503Paper 38717519Paper 38700353Paper 38699331Paper 38679747Paper 38657656Paper 38645169Paper 38643166Paper 38608634Paper 38597673Paper 38571760Paper 38565851Paper 38559037Paper 38477945Paper 38463959Paper 38458178Paper 38436133Paper 38405931Paper 38402617Paper 38400039Paper 38387080Paper 38352476Paper 38334805Trial NCT05016622Trial NCT04514484Trial NCT04401670Trial NCT03648983Trial NCT02774291Trial NCT02649569Trial NCT02578888Trial NCT02575872Trial NCT02527304Trial NCT02507076Trial NCT02382419Trial NCT02277561Trial NCT02112552Trial NCT02073968Trial NCT02038153Trial NCT02009436Trial NCT01958580Trial NCT01939210Trial NCT01899326Trial NCT01899261Trial NCT01897454Trial NCT01897441Trial NCT01857271Trial NCT01772420Trial NCT01697293Trial NCT01695941Trial NCT01605032Trial NCT01408160Trial NCT01367301Trial NCT01351909Trial NCT01319539Trial NCT01231906Trial NCT01145430Trial NCT01142401Trial NCT01061606Trial NCT01041027Trial NCT01001910Trial NCT00950365Trial NCT00470301Trial NCT00450944Trial NCT00437034Trial NCT00392353Trial NCT00324740Trial NCT00182767Trial NCT00179348Trial NCT00121251Trial NCT00096317Trial NCT00066638Trial NCT00057863Trial NCT00055692Trial NCT00030706Trial NCT00019474Trial NCT00004864Trial NCT00004863Trial NCT00003867Trial NCT00002461Patent 9671391Patent 7709613Patent 6821725Patent 6013468Patent 5876979

Abstract

The AECC DMA Sequencing Shared Resource was established in 1992 and has evolved considerably since then and, in particular, over the last funding period, to meet the evolving scientific needs of AECC members and programs. The new name of this facility, Genomics Shared Resource, reflects this expansion of services and technologies. The facility now offers, in addition to DMA sequencing, fragment analysis, dHPLC for SNP/mutation discovery, Pyrosequencing SNP typing, pyrosequencing quantitative CpG methylation, and Taqman SNP typing. Real-time PCR is now provided as well. At the time of the last CCSG review, this Facility provided Affymetrix services, and there was a separate cDNA printing facility. With the further development of microarray technologies, there has been a shift of emphasis to commercially available microarrays. To meet the needs for epigenetic studies, services were contracted with NimbleGen Direct to perform, on their site, gene expression, CGH, chromatin immunoprecipitation on microarrays (ChlP-chip), and a novel genome-wide cytosine methylation assay developed at AECC. NimbleGen services are managed by this facility. Within the context of this application all of the microarray services (Affymetrix, NimbleGen and in-house printing) have now been consolidated in this shared resource to provide a single source of intellectual guidance to users and enhance cost-effectiveness. The facility provides access to three computer workstations with design and analysis software to support a number of the services. Over the past five years the capacity of the facility has been increased so that turnaround time has been substantially decreased and fees to users have been decreased.

View original record on NIH RePORTER →